pentobarbital has been researched along with Cholangiitis, Sclerosing in 1 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Primary sclerosing cholangitis and nonspecific ulcerative colitis were modeled before and after serotonin and spiperone injections." | 1.35 | Role of the serotoninergic system in the development of diseases of the intestinal and biliferous tracts. ( Lychkova, AE, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lychkova, AE | 1 |
1 other study available for pentobarbital and Cholangiitis, Sclerosing
| Article | Year |
|---|---|
Role of the serotoninergic system in the development of diseases of the intestinal and biliferous tracts.
Topics: Animals; Cholangitis, Sclerosing; Colitis, Ulcerative; Dopamine Antagonists; GABA Modulators; Myocyt | 2009 |